Mike Ross, the former CSO at Arris Pharmaceuticals, and Research VP at Genentech, is now starting a company with its takeover already planned. MetaXen is effectively a newly-formed division of Xenova. Its mission is to help Xenova convert its leads into drug candidates.
You may also be interested in...
Confidence in the vaccine has slipped in the US, regardless of political affiliation.
Can "real world evidence" drive consumer health innovation? HBW Insight speaks to Orbital Research’s Chris Bunniss about RWE’s potential for the OTC industry.
Italy's Chiesi is looking to take a slice of Poland's consumer healthcare market by acquiring infant supplements specialist Smart Pharma.